Hypertension-Mediated Organ Damages should be Divided into Acute and ChronicCURRENT HIV RESEARCHIF12025-11-010PRE
THE SIGNIFICANCE OF CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME IN HYPERTENSIVE PATIENTS高血压患者中心血管-肾脏-代谢综合征的意义JOURNAL OF HYPERTENSIONIF4.12025-05-010PRE
Introducing the Concept of Hypertensive Heart Disease to Improve Hypertensive Left Ventricular Hypertrophy引入高血压心脏病概念以改善高血压左心室肥厚CURRENT VASCULAR PHARMACOLOGYIF2.12025-01-230PRE
Immune Cell-Based versus Albumin-Based Ratios as Outcome Predictors in Critically Ill COVID-19 Patientsinflammation researchIF4.12025-01-010OA
From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?BIOMEDICINESIF3.92022-10-187OAAI
Low-Frequency Magnetic Resonance Imaging Identifies Hand Joint Subclinical Inflammation in Systemic SclerosisDIAGNOSTICSIF3.32022-09-063OAAI
Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19JOURNAL OF CLINICAL MEDICINEIF2.92021-12-125OAAI
The effects of intraoperative hypothermia on cytokine profile: A randomized pilot studyJOURNAL OF CLINICAL ANESTHESIAIF5.12020-08-010PREAI
PRESENCE OF ASYMPTOMATIC PERIPHERAL ARTERY DISEASE AMONG HYPERTENSIVE PATIENTS WITH CORONARY DISEASEJOURNAL OF HYPERTENSIONIF4.12019-07-010OAAI
RISK FACTORS FOR LEFT VENTRICULAR MASS CHANGES DURING ANTIHYPERTENSIVE TREATMENT IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK: A 7-YEAR FOLLOWS UP STUDYJOURNAL OF HYPERTENSIONIF4.12019-07-010PREAI
Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?MEDIATORS OF INFLAMMATIONIF4.22018-07-15165OAAI
THE PRESENCE OF GLUCOSE METABOLIC DISORDERS AND SUBCLINICAL RENAL IMPAIRMENT IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASEJOURNAL OF HYPERTENSIONIF4.12018-06-010PREAI
PROGNOSTIC SIGNIFICANCE OF VISIT-TO-VISIT VARIABILITY, MEAN AND MAXIMUM BLOOD PRESSURE IN TREATED HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISKJOURNAL OF HYPERTENSIONIF4.12018-06-010PREAI
THE PREVALENCE OF METABOLIC SYNDROME IN PATIENTS WITH HYPERTENSION AND ITS IMPACT ON ASYMPTOMATIC CAROTID ATHEROSCLEROSISJOURNAL OF HYPERTENSIONIF4.12017-09-010PREAI
FIFTEEN-YEAR PROGNOSTIC SIGNIFICANCE OF ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ARTERIAL HYPERTENSIONJOURNAL OF HYPERTENSIONIF4.12017-09-010PREAI
PREDICTORS OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISKJOURNAL OF HYPERTENSIONIF4.12017-09-010PREAI
EVALUATION OF HYPERTENSIVE PATIENTS: TEN YEARS PROGNOSTIC SIGNIFICANCE OF NON-INVASIVE PARAMETERSJOURNAL OF HYPERTENSIONIF4.12016-09-010PREAI
THE IMPACT OF SERUM URIC ACID ON ASYMPTOMATIC CAROTID ATHEROSCLEROSIS AND RENAL DISEASE IN HYPERTENSIVE PATIENTSJOURNAL OF HYPERTENSIONIF4.12016-09-010PREAI
METABOLIC SYNDROME AS THE PREDICTOR OF NEW CARDIOVASCULAR EVENTS IN PATIENTS WITH MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTIONJOURNAL OF HYPERTENSIONIF4.12016-09-010PREAI
THE IMPACT OF ARTERIAL HYPERTENSION ON MORTALITY IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATIONJOURNAL OF HYPERTENSIONIF4.12016-09-010PREAI